Published in
Wiley, Cochrane Library, 7(2014), 2014
DOI: 10.1002/14651858.cd010253.pub2
Protocols
DOI: 10.1002/14651858.cd010253
Links
Tools
Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients
Journal article published in 2012 by
Luit Penninga,
André Wettergren,
Colin H. Wilson,
An-Wen Chan,
Daniel A. Steinbrüchel,
Christian Gluud 
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Liver transplantation is an established treatment option for end-stage liver failure. To date, no consensus has been reached on the use of immunosuppressive T-cell antibody induction for preventing rejection after liver transplantation.